Daniel Von-hoff, M.d
Scientific Advisory Board
MBC Pharma, Inc.
Colombia
Biography
Dr. Von Hoff is one of the world’s most experienced and respected clinical oncologists and oncology drug developers, having conducted national clinical trials with more than 200 new antineoplastic and biologic agents (more than any other investigator). Dr. Von Hoff has served as Director of the Arizona Cancer Center and Professor of Medicine at The University of Arizona Health Sciences Center, the President of the American Association for Cancer Research, and a Member of the Board of Scientific Advisors of the National Cancer Institute. He has served on the FDA’s Oncology Advisory Committee and the board of the American Society of Clinical Oncology. Dr. Von Hoff was appointed to President Bush’s National Cancer Advisory Board in June 2004 through March 2010. He is a founder of ILEX Oncology, Inc. (acquired by Genzyme). He is founder and the Editor Emeritus of Investigational New Drugs; The Journal of New Anticancer Agents; and, Editor-in-Chief of Molecular Cancer Therapeutics. Dr. Von Hoff has published more than 500 papers, and 129 book chapters.
Research Interest
Business
